Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Cancer Genetics Inc (NQ: CGIX)
0.8455 USD  +0.0155 (+1.87%)
Streaming Delayed Price  /  Updated: 2:08 PM EDT, Oct 16, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 95,419
Open 0.8200
Bid (Size) 0.8110 (5)
Ask (Size) 0.8455 (3)
Prev. Close 0.8300
Today's Range 0.8101 - 0.8455
52wk Range 0.8000 - 3.500
Shares Outstanding 27,746,497
Dividend Yield N/A
Performance
YTD
-56.64%
-56.64%
1 Month
-20.24%
-20.24%
3 Month
-2.25%
-2.25%
6 Month
-36.90%
-36.90%
1 Year
-68.69%
-68.69%
Top News
More News
Cancer Genetics Issues Letter to Shareholders
Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced the publication of a letter to... Read More
from GlobeNewswire News Releases
Cancer Genetics and Cellaria Partner on Precision Medicine Tools
Collaboration focused on developing pharmacology models to support biopharma R&D Read More
from GlobeNewswire News Releases
More News
Read More
Cancer Genetics Enters Supply Agreement with Agilent Technologies
from GlobeNewswire News Releases
Cancer Genetics Offers Oncomine Comprehensive Assay to Drive Clinical Trials
from GlobeNewswire News Releases
Chardan Advises NovellusDX in Cross-Border Biotech Merger
from PR Newswire
Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge
from GlobeNewswire News Releases
Cancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business Updates
from GlobeNewswire News Releases
Cancer Genetics to Report Second Quarter 2018 Financial Results on August 14, 2018
from GlobeNewswire News Releases
Cancer Genetics Closes $2.625 million Convertible Note Financing
from GlobeNewswire News Releases
Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer
from GlobeNewswire News Releases
FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cancer Genetics, Inc. (CGIX) and Lead Plaintiff Deadline - June 4, 2018
from ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.